Balrampur Chini Mills raises ₹450cr, boosts 2026 capex

What the board approved on April 23, 2026

Balrampur Chini Mills has approved a set of funding and expansion decisions centred on its upcoming Poly Lactic Acid (PLA) business. In a board meeting held on April 23, 2026, the company cleared a ₹450 crore preferential issue of equity shares. Alongside the equity raise, it also revised the capital expenditure for its 80,000 tonnes per annum PLA project upward to ₹3,080 crore. The board also sanctioned a new lactogypsum processing facility in Kumbhi, Uttar Pradesh, with an investment of up to ₹160 crore.

The company additionally approved raising up to ₹200 crore through listed, secured non-convertible debentures (NCDs) on a private placement basis. The meeting began at 11:00 AM and concluded at 2:45 PM on April 23, 2026, as per the details shared. Shareholders will vote on the preferential issue and related proposals at an Extraordinary General Meeting (EGM) scheduled for May 20, 2026.

Preferential issue: size, price, and share count

The preferential allotment is for up to 93,16,771 fully paid-up equity shares. The issue price is set at ₹483 per share, which includes a premium of ₹482 per share. Based on the approved terms, the total mobilisation works out to ₹450 crore.

The stated objective of the equity issuance is to support the company’s expanding capital expenditure plans and strategic initiatives. The allotment spans multiple investor categories, including promoters, a promoter group entity, and non-promoter institutional investors.

Who is participating in the issue

The company disclosed that the preferential issue covers 11 investor categories, including promoters, promoter group members, and institutional investors. On the promoter side, Vivek Saraogi and Sumedha Saraogi have been allotted 24,00,000 and 3,45,864 shares respectively. Meenakshi Mercantiles Limited, a promoter group entity, has been allotted 12,50,000 shares.

Among non-promoter investors, names cited include Tata Small Cap Fund, Ikigai Emerging Equity Fund, 360 One Pipe Fund, Alchemy funds, and multiple ICICI Prudential schemes. The company’s disclosure highlights Tata Small Cap Fund as the single largest investor by value within the institutional bucket.

Preferential issue allocation (selected categories)

Note: Investment amounts are converted to ₹ crore and rounded; totals may differ marginally due to rounding.

The company also stated that promoters would infuse ₹193 crore through the preferential issue.

PLA project capex raised to ₹3,080 crore

A key outcome of the board meeting was the revision in the PLA project’s capital expenditure from ₹2,850 crore to ₹3,080 crore. This implies a cost escalation of ₹230 crore against the earlier estimate. The company attributed the increase to higher prices of key construction materials, global supply chain disruptions, and engineering and design changes emerging during the modelling review.

The PLA project is planned at 80,000 tonnes per annum. Funding for the revised capex is expected to come from a mix of equity proceeds from the preferential issue, debt financing, and internal accruals. The company positioned this as an approach aimed at maintaining flexibility while meeting the higher project outlay.

New lactogypsum processing plant in Kumbhi, Uttar Pradesh

The board also approved setting up a Lactogypsum Processing Plant at Kumbhi, Uttar Pradesh, with an estimated investment of up to ₹160 crore. The plant will process lactogypsum generated as a by-product from the company’s PLA manufacturing operations.

The facility is planned with an installed capacity of approximately 76 lakh gypsum boards per annum. Commercial production is expected by December 2027, subject to receipt of necessary approvals. The company also indicated that a portion of the net proceeds from the preferential issue, up to ₹160 crore, may be used for funding this project.

Additional funding: up to ₹200 crore via listed, secured NCDs

Beyond equity, the board approved issuance of listed, secured non-convertible debentures aggregating up to ₹200 crore through private placement. The issuance may be done in one or more tranches.

The company said specific terms such as tenure, coupon rate, and security details will be disclosed at the time of each allotment. The NCD approval is positioned as an additional lever to fund growth initiatives and maintain financial flexibility.

Key numbers at a glance

Dates investors will track

The company has scheduled an EGM for May 20, 2026, to seek shareholder approval for the preferential issue and other board-approved initiatives. Separately, it has scheduled a conference call for investors and analysts on April 28, 2026 at 12:00 Noon IST to discuss PLA project updates and the capital-raising steps.

These dates matter because the preferential allotment requires shareholder approval, and the company has linked the fundraise to capex and project execution plans disclosed alongside the PLA and gypsum initiatives.

Company profile and recent stock performance

Balrampur Chini Mills operates as an integrated sugar company with ten sugar factories in Uttar Pradesh. It has an aggregate sugarcane crushing capacity of 80,000 tonnes per day (TCD), distillery operations of 1,050 kilo litre per day (KLPD), and cogeneration capacity of 175.7 MW.

The stock’s historical returns provided in the disclosure show: 1-day return of -0.23%, 5-day return of +11.32%, 1-month return of +11.20%, 6-month return of +15.28%, 1-year return of -8.67%, and 5-year return of +101.87%.

Why this matters

The board’s decisions combine fresh equity, proposed debt headroom, and a revised project budget for a new manufacturing vertical in PLA. The additional gypsum facility indicates plans to monetise a by-product stream from PLA operations, with a defined commercial production timeline of December 2027 (subject to approvals).

In the near term, the next formal milestones are the April 28 investor call and the May 20 EGM. The company has indicated that further details on the NCD terms will be shared at the time of each tranche allotment, keeping investors focused on subsequent disclosures.